Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccine Efficacy
New vaccine efficacy data have been reported by B. Cipriani and co-authors
October 15th, 2008
"The aim of this study was to evaluate the efficacy of genetic vaccination with rat ErbB2 antigen in a therapeutic setting for the BALB-neuT mouse model of mammary carcinoma and to establish immunological correlates with vaccine efficacy. To define an early therapeutic setting we performed imaging studies of mouse mammary glands with a high-frequency ultrasound system that allowed the diagnosis of tumor lesions before they become palpable, starting from week 13 after mouse births," researchers in Pomezia, Italy report. "An intensive immunization protocol of vaccination was implemented at this stage, consisting of four weekly DNA injections with electroporation followed...
Source: Vaccine Weekly (2008-10-15)
|
